Govindaswami Ragupathi

Author

Memorial Sloan Kettering Cancer Center

Also Known As

G Ragupathi, G. Ragupathi, Govindaswami Ragupathi, Ragupathi G

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Kettering University Columbia University Memorial Hospital

About

Govindaswami Ragupathi is an author at Memorial Sloan Kettering Cancer Center specializing in immunotherapy, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.6K
2	Natural Sciences	3	3	156
3	Allergy	3	3	461
4	Biochemistry	3	3	156
5	Biomolecular Engineering	2	2	109

Govindaswami Ragupathi

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man Susan F. Slovin, Govindaswami Ragupathi, Sucharita Adluri, Proceedings of the National Academy of Sciences Immunocytochemical TechniqueImmunologyImmunoeditingPathologyAntigen Processing	1999	253
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial Teresa Gilewski, Govindaswami Ragupathi, Sonal Bhuta, Proceedings of the National Academy of Sciences Breast OncologyAllergyMedicineImmunologyGlobo H	2001	204
Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens: The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer Scott D. Kuduk, Jacob B. Schwarz, Xiaotao Chen, Journal of the American Chemical Society ImmunologyImmunoeditingImmunodominanceAntigen ProcessingImmunotherapeutics	1998	204
Fully Synthetic Carbohydrate-Based Vaccines in Biochemically Relapsed Prostate Cancer: Clinical Trial Results With α-<i>N</i>-Acetylgalactosamine-<i>O</i>-Serine/Threonine Conjugate Vaccine Susan F. Slovin, Govindaswami Ragupathi, Cristina Musselli, Journal of Clinical Oncology	2003	171
Immunization of ovarian cancer patients with a synthetic Lewisy-protein conjugate vaccine: A phase 1 trial Paul Sabbatini, Valery Kudryashov, Govindaswami Ragupathi, International Journal of Cancer	2000	125
Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21 Govindaswami Ragupathi, Michael L. Meyers, Sucharita Adluri, International Journal of Cancer	2000	124
Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines Soo Kie Kim, Govindaswami Ragupathi, Cristina Musselli, Vaccine VaccinationDifferent Immunological AdjuvantsCancer ImmunosurveillanceT-cell ResponseImmunology	1999	112
On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines Govindaswami Ragupathi, Don M. Coltart, Lawrence J. Williams, Proceedings of the National Academy of Sciences	2002	111
Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer. Maura N. Dickler, Govindaswami Ragupathi, Nancy X. Liu, PubMed ImmunologyPathologyImmunotherapeuticsImmunotherapyGlioma	1999	91
Immunization of Mice with a Fully Synthetic Globo H Antigen Results in Antibodies against Human Cancer Cells: A Combined Chemical—Immunological Approach to the Fashioning of an Anticancer Vaccine Govindaswami Ragupathi, Tae Kyo Park, Shengle Zhang, Angewandte Chemie International Edition in English ImmunologyImmunodominanceImmunotherapeuticsImmune Cell TherapyImmune System	1997	90

Page 1